Atlas FDA

LINX Reflux Management System

FDA premarket approval P100049/S030 · decided 2022-01-07

Approval details

PMA number
P100049
Supplement
S030
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
LINX Reflux Management System
Generic name
IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX
Applicant
Torax Medical
Date received
2021-12-10
Decision date
2022-01-07
Days to decision
28 days
Decision code
OK30
Product code
LEI
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Cincinnati, OH
Statement
30-Day Notice Supplement in accordance with the letter from FDA following review of the Annual Report.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.